Skip to Content

Haematologic Technologies is a large molecule CRO unlike any other. Combining world class protein chemistry expertise, integrated large molecule analytical services, and customized products to support biopharma R&D, we accelerate large molecule drug development for clients around the globe.

Here's what makes us different!

Large Molecule Focus

  • Plasma (Native) Protein and Antibody Therapeutics
  • Recombinant Protein and Antibody Therapeutics (mAb's, Polyclonals)
  • Antibody Drug Conjugates (ADC's)
  • Cell and Gene Therapy
  • Vaccines / Viral Vectors

Specific Therapeutic Areas of Expertise

  • Rare Diseases: Hemophilia, Duchenne Muscular Dystrophy, Other rare genetic disorders
  • Immuno-therapeutics: Hyperimmunes, IVIG, Allergy, Auto-immune disorders
  • Oncology: Immuno-oncology, blood cancers
  • Coagulation: Clotting/Bleeding Disorders; Therapeutics impacting on Hemostasis
  • General: Expertise in a wide range of other therapeutic areas